JPRN-UMIN000047330
Completed
未知
A Prospective Natural History Study of Patients with Intractable Venous Malformation and Klippel-Trenaunay Syndrome - A Prospective Natural History Study of Patients with Intractable Venous Malformation and Klippel-Trenaunay Syndrome
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Venous malformation and Klippel-Trenaunay Syndrome
- Sponsor
- ARTham Therapeutics Inc.
- Enrollment
- 34
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients for whom MRI scan is difficult or impossible to perform and whose lesions are difficult to be evaluated by MRI due to artifacts (e.g., patients who have electronic devices in their body such as cardiac pacemakers, implantable cardioverter defibrillators (ICDs), ventricular shunts, orthodontic appliances, cochlear implants neurostimulators or spinal cord stimulators, who need sedation for MRI scan but have risk to use it, and who are uncomfortable in closed or dark areas, etc.) 2\)Patients whose lesion volume is difficult to measure by MRI (e.g., lesions for which the long and short diameters of the maximum cross\-sectional area to be evaluated are unclear). 3\)Patients who received invasive treatment including sclerotherapy or resection surgery for the target lesions within 12 weeks at obtaining consent, regardless of the classification of treatment, clinical research, or clinical trial 4\)Patients who participated in any clinical trials (excluding observational studies) within 12 weeks at obtaining consent. 5\)Patients who are judged by the investigator not to be eligible for the study (e.g., problems with cognitive function, comprehension, or compliance with hospital visits).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A prospective observational study of patients with advanced cancer for the evaluation of checkpoint inhibitor-associated cardiovascular immune-related adverse eventsAdvanced non-small-cell lung cancer and advanced gastric cancer which are indications for anti-cytotoxic T-lymphocyte-associated antigen-4, anti-programmed death-1, and anti-programmed death-ligand 1 antibodies.JPRN-UMIN000032729Frontline Immunotherapy Team, Sendai Kousei Hospital129
Recruiting
Not Applicable
A prospective observational study of patients with ankle sprain and instability in Korean Medicine clinics and hospitalKCT0004016Gachon University200
Not yet recruiting
Not Applicable
A Prospective Observational Study of patients who switched from SGLT2 inhibitor tablets to luseogliflozin OD film formulation in terms of feeling, Efficacy and Safety of taking the medicine.Type 2 Diabetes MellitusJPRN-UMIN000050476Seino internal Medicine Clinic60
Recruiting
Not Applicable
A prospective observational study for patients with community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia in a Japanese University Hospitalcommunity-acquired (CAP), health-care-associated (HCAP), hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)JPRN-UMIN000007090Department of Respiratory Medicine, Nagoya University Graduate School of Medicine1,420
Not yet recruiting
Not Applicable
A CLINICAL STUDY AMONG PATIENTS OF PRIMARY CUTANEOUS AMYLOIDOSIS REGARDING DISEASE SYMPTOMS AND ITS CAUSES USING SKIN BIOPSY RESULTS AND DERMOSCOPYCTRI/2022/11/047739I